Resources | NITAG RESOURCE CENTER

2024 ∙ NACI

Guidance on an additional dose of COVID-19 vaccines in the spring for individuals at high risk of severe illness due to COVID-19

2023 ∙ Xiao, Hong Vaidya, Riha Liu, Fang Chang, Ximing Xia, Xiaoqian Unger, Joseph M.

Sex, Racial, and Ethnic Representation in COVID-19 Clinical Trials: A Systematic Review and Meta-analysis

2023 ∙ CAVEI

CAVEI recommendation on updating the vaccination strategy against COVID-19 by 2024

2023 ∙ CoNaIn

CoNaIn 9th November 2023 meeting minutes

2023 ∙ NACI

Updated guidance on the use of COVID-19 vaccines in individuals who have not previously been vaccinated against COVID-19

2023 ∙ ACIP

Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged ≥6 Months — United States, April 2023

2023 ∙ NACI

Guidance on the use of COVID-19 vaccines in the fall of 2023

2023 ∙ NACI

NACI Interim guidance on the use of bivalent Omicroncontaining COVID-19 vaccines for primary series

2023 ∙ NACI

Guidance on an additional COVID-19 booster dose in the spring of 2023 for individuals at high risk of severe illness due to COVID-19

2023 ∙ NACI

NACI guidance on COVID-19 vaccine booster doses: Initial considerations for 2023